Colin C. Pritchard

9.2k total citations · 3 hit papers
41 papers, 6.1k citations indexed

About

Colin C. Pritchard is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Colin C. Pritchard has authored 41 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 17 papers in Oncology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Colin C. Pritchard's work include Cancer Genomics and Diagnostics (12 papers), Prostate Cancer Treatment and Research (12 papers) and PARP inhibition in cancer therapy (10 papers). Colin C. Pritchard is often cited by papers focused on Cancer Genomics and Diagnostics (12 papers), Prostate Cancer Treatment and Research (12 papers) and PARP inhibition in cancer therapy (10 papers). Colin C. Pritchard collaborates with scholars based in United States, United Kingdom and Germany. Colin C. Pritchard's co-authors include Jonathan F. Tait, Jason D. Arroyo, Muneesh Tewari, Evan M. Kroh, Patrick S. Mitchell, Donald Gibson, John R. Chevillet, Ingrid K. Ruf, Era L. Pogosova‐Agadjanyan and Christopher F. Bennett and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Colin C. Pritchard

41 papers receiving 6.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma

2011 2.7k citations Jason D. Arroyo, Evan M. Kroh et al. profile →
Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies

2011 734 citations Colin C. Pritchard, Evan M. Kroh et al. Cancer Prevention Research profile →
Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas

2013 712 citations Kathryn P. Pennington, Tom Walsh et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Colin C. Pritchard United States	22	4.1k	3.6k	1.2k	719	716	41	6.1k
August Vidal Spain	38	3.1k 0.8×	1.7k 0.5×	856 0.7×	257 0.4×	484 0.7×	110	5.2k
Lars Holmgren Sweden	42	4.7k 1.1×	2.3k 0.6×	1.5k 1.2×	617 0.9×	547 0.8×	77	7.6k
Orla Sheils Ireland	36	2.1k 0.5×	1.4k 0.4×	817 0.7×	265 0.4×	376 0.5×	115	4.1k
Deborah J. Marsh Australia	43	4.2k 1.0×	1.3k 0.4×	1.8k 1.5×	1.3k 1.8×	456 0.6×	130	7.4k
Vundavalli V. Murty United States	40	4.4k 1.1×	1.3k 0.4×	1.9k 1.6×	862 1.2×	687 1.0×	109	7.2k
Geneviève Laureys Belgium	39	2.3k 0.6×	1.4k 0.4×	1.4k 1.1×	730 1.0×	420 0.6×	165	5.1k
Triantafillos Liloglou United Kingdom	42	5.1k 1.2×	1.7k 0.5×	2.1k 1.7×	753 1.0×	1.2k 1.6×	148	7.7k
Jerry S. Lanchbury United States	44	2.3k 0.6×	1.4k 0.4×	2.0k 1.6×	1.5k 2.1×	1.8k 2.5×	163	7.7k
Helge Täubert Germany	42	4.3k 1.1×	2.3k 0.6×	2.9k 2.4×	519 0.7×	1.3k 1.9×	247	7.1k
Rajesha Rupaimoole United States	23	4.5k 1.1×	3.8k 1.0×	731 0.6×	147 0.2×	320 0.4×	41	6.0k

Countries citing papers authored by Colin C. Pritchard

Since Specialization

Citations

This map shows the geographic impact of Colin C. Pritchard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Colin C. Pritchard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Colin C. Pritchard more than expected).

Fields of papers citing papers by Colin C. Pritchard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Colin C. Pritchard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Colin C. Pritchard. The network helps show where Colin C. Pritchard may publish in the future.

Co-authorship network of co-authors of Colin C. Pritchard

This figure shows the co-authorship network connecting the top 25 collaborators of Colin C. Pritchard. A scholar is included among the top collaborators of Colin C. Pritchard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Colin C. Pritchard. Colin C. Pritchard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Graham, Laura, Roman Gulati, Colin C. Pritchard, et al.. (2025). Association of Prior PARP Inhibitor Exposure with Clinical Outcomes after 177Lu-PSMA-617 in Men with Castration-resistant Prostate Cancer and Mutations in DNA Homologous Recombination Repair Genes. European Urology Oncology. 2 indexed citations

Linch, Mark, Gianmarco Leone, Yien Ning Sophia Wong, et al.. (2024). Nivolumab and ipilimumab for metastatic prostate cancer with an immunogenic signature: The NEPTUNES multi-centre two-cohort, biomarker-selected phase 2 trial.. Journal of Clinical Oncology. 42(16_suppl). 5013–5013. 5 indexed citations

Yu, Evan Y., Roman Gulati, Matthew B. Rettig, et al.. (2023). Final results of a pilot study of docetaxel and carboplatin for treatment of patients with mCRPC containing biallelic inactivation of genes in the homologous recombination DNA repair pathway.. Journal of Clinical Oncology. 41(16_suppl). 5054–5054. 1 indexed citations

Paulson, Vera, Jennifer A. Hempelmann, Mallory Beightol, et al.. (2020). Validation and implementation of a modular targeted capture assay for the detection of clinically significant molecular oncology alterations. Practical Laboratory Medicine. 19. e00153–e00153. 36 indexed citations

Barnell, Erica K., Adam Waalkes, Kelsi Penewit, et al.. (2019). Open-Sourced CIViC Annotation Pipeline to Identify and Annotate Clinically Relevant Variants Using Single-Molecule Molecular Inversion Probes. JCO Clinical Cancer Informatics. 3(3). 1–12. 6 indexed citations

Keel, Sioḃán, Angela Scott, Marilyn Sánchez-Bonilla, et al.. (2016). Genetic features of myelodysplastic syndrome and aplastic anemia in pediatric and young adult patients. Haematologica. 101(11). 1343–1350. 107 indexed citations

Mateo, Joaquı́n, Gunther Boysen, Christopher E. Barbieri, et al.. (2016). DNA Repair in Prostate Cancer: Biology and Clinical Implications. European Urology. 71(3). 417–425. 162 indexed citations

Austin, Melissa, Christina Smith, Colin C. Pritchard, & Jonathan F. Tait. (2015). DNA Yield From Tissue Samples in Surgical Pathology and Minimum Tissue Requirements for Molecular Testing. Archives of Pathology & Laboratory Medicine. 140(2). 130–133. 19 indexed citations

Lin, Edward H., Xiaowei Yan, Fang Xie, et al.. (2015). PI3K/APC pathway and cyclin-dependent kinase pathway to predict complete responders in CRC patients treated with ADAPT therapy.. Journal of Clinical Oncology. 33(15_suppl). e14642–e14642. 1 indexed citations

10.

Shirts, Brian H., Stephen J. Salipante, Silvia Casadei, et al.. (2014). Deep sequencing with intronic capture enables identification of an APC exon 10 inversion in a patient with polyposis. Genetics in Medicine. 16(10). 783–786. 13 indexed citations

11.

Pennington, Kathryn P., Tom Walsh, Maria I. Harrell, et al.. (2013). Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas. Clinical Cancer Research. 20(3). 764–775. 712 indexed citations breakdown →

12.

Hiatt, Joseph B., Colin C. Pritchard, Stephen J. Salipante, Brian J. O’Roak, & Jay Shendure. (2013). Single molecule molecular inversion probes for targeted, high-accuracy detection of low-frequency variation. Genome Research. 23(5). 843–854. 227 indexed citations

13.

Pritchard, Colin C., Stephen J. Salipante, Karen M. Koehler, et al.. (2013). Validation and Implementation of Targeted Capture and Sequencing for the Detection of Actionable Mutation, Copy Number Variation, and Gene Rearrangement in Clinical Cancer Specimens. Journal of Molecular Diagnostics. 16(1). 56–67. 196 indexed citations

14.

Pritchard, Colin C., Christina Smith, Karen M. Koehler, et al.. (2013). A mosaic PTEN mutation causing Cowden syndrome identified by deep sequencing. Genetics in Medicine. 15(12). 1004–1007. 28 indexed citations

15.

Pritchard, Colin C., Evan M. Kroh, Brent L. Wood, et al.. (2011). Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies. Cancer Prevention Research. 5(3). 492–497. 734 indexed citations breakdown →

16.

Pritchard, Colin C. & Peter S. Nelson. (2008). Gene expression profiling in the developing prostate. Differentiation. 76(6). 624–640. 34 indexed citations

17.

Bianchi‐Frias, Daniella, Colin C. Pritchard, Brigham H. Mecham, Ilsa M. Coleman, & Peter S. Nelson. (2007). Genetic background influences murine prostate gene expression: implications for cancer phenotypes. Genome biology. 8(6). R117–R117. 20 indexed citations

18.

Khodavirdi, Ani C., Zhigang Song, Shangxin Yang, et al.. (2006). Increased Expression of Osteopontin Contributes to the Progression of Prostate Cancer. Cancer Research. 66(2). 883–888. 97 indexed citations

19.

Guo, Lili, et al.. (2001). Artificial ion channels formed by a synthetic cyclic peptide. Journal of Peptide Research. 57(4). 301–306. 32 indexed citations

20.

Macintyre, Sally & Colin C. Pritchard. (1989). Comparisons between the self-assessed and observer-assessed presence and severity of colds. Social Science & Medicine. 29(11). 1243–1248. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact